logo
Book a meeting
Karma Biotechnologies

Karma Biotechnologies

Biotechnology, 370 Amapola Ave Ste 101, Los Angeles, California, 90501, United States, 1-10 Employees

karmabiotech.com

  • twitter
  • LinkedIn

phone no Phone Number: 81********

Who is KARMA BIOTECHNOLOGIES

Karma is a proud IndieBio company! We're thrilled to be in the current IBSF14 cohort. Metastatic cancer can be cured by cytokine immunotherapies, but only for a lucky few (about 7% of pat...

Read More

lock icon Get Full Access
map
  • 370 Amapola Ave Ste 101, Los Angeles, California, 90501, United States Headquarters: 370 Amapola Ave Ste 101, Los Angeles, California, 90501, United States
  • 2017 Date Founded: 2017
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • Andrew Gray CEO:   Andrew Gray

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from KARMA BIOTECHNOLOGIES

Karma Biotechnologies Org Chart and Mapping

Andrew Gray

Andrew Gray

Cofounder and CEO

Employees
Xazmin Custer

Xazmin Custer

Associate Director

See Full Org Chart arrow
email-formate-icon
View Email Formats for Karma Biotechnologies
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Karma Biotechnologies

Answer: Karma Biotechnologies's headquarters are located at 370 Amapola Ave Ste 101, Los Angeles, California, 90501, United States

Answer: Karma Biotechnologies's phone number is 81********

Answer: Karma Biotechnologies's official website is https://karmabiotech.com

Answer: Karma Biotechnologies's revenue is $1 Million to $5 Million

Answer: Karma Biotechnologies's SIC: 8731

Answer: Karma Biotechnologies has 1-10 employees

Answer: Karma Biotechnologies is in Biotechnology

Answer: Karma Biotechnologies contact info: Phone number: 81******** Website: https://karmabiotech.com

Answer: Karma is a proud IndieBio company! We're thrilled to be in the current IBSF14 cohort. Metastatic cancer can be cured by cytokine immunotherapies, but only for a lucky few (about 7% of patients). Karma is making these medicines safe and effective for the other 93% by engineering immune cells to manufacture cytokines and other biologicals locally within the tumor, exactly where they're needed.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access